Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy.
Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy.
复制标题
DOI:
10.1016/j.yjmcc.2015.11.004
复制
发表时间:
2015-12
影响因子:
5
通讯作者:
Verma SK
中科院分区:
文献类型:
--
作者:
Kishore R;Krishnamurthy P;Garikipati VN;Benedict C;Nickoloff E;Khan M;Johnson J;Gumpert AM;Koch WJ;Verma SK
Although autophagy is an essential cellular salvage process to maintain cellular homeostasis, pathological autophagy can lead to cardiac abnormalities and ultimately heart failure. Therefore, a tight regulation of autophagic process would be important to treat chronic heart failure. Previously, we have shown that IL-10 strongly inhibited pressure overload-induced hypertrophy and heart failure, but role of IL-10 in regulation of pathological autophagy is unknown. Here we tested the hypothesis that IL-10 inhibits angiotensin II-induced pathological autophagy and this process, in part, leads to improve cardiac function. Chronic Ang II strongly induced mortality, cardiac dysfunction in IL-10 Knockout mice. IL-10 deletion exaggerated pathological autophagy in response to Ang II treatment. In isolated cardiac myocytes, IL-10 attenuated Ang II-induced pathological autophagy and activated Akt/mTORC1 signaling. Pharmacological or molecular inhibition of Akt and mTORC1 signaling attenuated IL-10 effects on Ang II-induced pathological autophagy. Furthermore, lysosomal inhibition in autophagic flux experiments further confirmed that IL-10 inhibits pathological autophagy via mTORC1 signaling. Our data demonstrate a novel role of IL-10 in regulation of pathological autophagy; thus can act as a potential therapeutic molecule for treatment of chronic heart disease.